Physician profile
Jay Oaks
NPI 1790786085
$4,813.95
in general payments reported to CMS, 2019-2025
16 companies · $478 in 2025
The $478 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2021: $986 · 2022: $309 · 2023: $2,460 · 2024: $252 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959 · Travel and Lodging: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.15 |
| Travel and Lodging | $1,230.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,406.23 | 2023-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $1,054.75 | 2022-2023 | Valiant Captivia |
| Camber Spine Technologies LLC | $985.68 | 2021 | |
| Silk Road Medical, INC. | $696.23 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $296.54 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Surmodics, INC. | $100.44 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Acera Surgical, INC. | $63.18 | 2023-2025 | Restrata Wound Matrix |
| Daiichi Sankyo INC. | $50.05 | 2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $35.70 | 2023 | Assure Wcd |
| Boston Scientific Corporation | $33.10 | 2025 | Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $21.26 | 2024 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $20.89 | 2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $19.37 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.73 | 2025 | Jardiance |
| Lemaitre Vascular, INC. | $8.90 | 2023 | Artegraft Vascular Graft |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $3.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Oaks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.